机译:BRAF V600E和REDICICICAL在放射性碘 - 难治性乳头状甲状腺癌中
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
Tech Univ Munich Dept Pathol Munich Germany;
Natl Ctr Tumor Dis NCT Heidelberg Tissue Bank Heidelberg Germany;
Natl Ctr Tumor Dis NCT Heidelberg Tissue Bank Heidelberg Germany;
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
Heidelberg Univ Hosp Dept Nucl Med Heidelberg Germany;
Heidelberg Univ Hosp Dept Nucl Med Heidelberg Germany;
Heidelberg Univ Hosp Dept Nucl Med Heidelberg Germany;
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
Heidelberg Univ Hosp Dept Endocrinol &
Clin Chem Heidelberg Germany;
differentiated thyroid cancer; radioiodine therapy; retinoic acid; genetic markers;
机译:BRAF V600E和REDICICICAL在放射性碘 - 难治性乳头状甲状腺癌中
机译:韩国放射性碘难治性乳头状甲状腺癌患者联合131I和视黄酸联合治疗。
机译:放射性碘难治性乳头状甲状腺癌患者中 131 sup> I与维甲酸联合治疗
机译:从概念到诊所的机器学习:使用高尺寸RNA表达数据可靠地检测甲状腺结节中的BRAF V600E DNA突变
机译:甲状腺激素受体和视黄酸受体的分子分析:DNA识别特异性以及在内分泌疾病和癌症中的作用。
机译:与PD98059和PLX4032协同抑制MEK / ERK和BRAF V600E会诱导BRAF突变的甲状腺乳头状癌细胞中钠/碘同向转运蛋白(NIS)的表达和放射性碘的吸收
机译:甲状腺乳头状微癌的临床结局,BRAF(V600E)的作用以及分子途径:是惰性癌症还是甲状腺乳头状癌的早期阶段?